FDA drug approvals December 2014
FDA actions in briefFDA has approved the new drug application (NDA) for liraglutide [rDNA origin] injection (Saxenda, Novo Nordisk) , the first once-daily glucagon-like peptide-1 (GLP-1) receptor...
View ArticleXtoro approved for swimmer's ear
FDA has approved finafloxacin (Xtoro, Alcon) otic suspension for the treatment of otitis externa.FDA drug approvals-December 2014 Otitis externa, commonly known as swimmer’s ear, is an inflammation or...
View Article
More Pages to Explore .....